Population
Hypertensive patients, patients with ischemic heart disease, and patients with dilated cardiomyopathy.
Design
Review
Authors
Loading...
Supports ACE inhibitor preference in select hypertensives and short-acting CCB caution; leaves open updated RCTs on nondihydropyridine effects.
This review highlights the preferred use of ACE inhibitors in specific high-risk hypertensive patients and cautions against the use of short-acting CCBs due to potential adverse coronary events.
Marvin Moser (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: